Articles

Merck & Co. said Thursday it’s discontinuing a late-stage trial of a treatment for patients with extensive-stage small cell lung cancer after patients experienced a high rate of adverse events.

Under Armour Inc.’s stock rose 7.7% premarket Thursday after the athletic-apparel maker beat Wall Street’s top and bottom-line expectations in its first-quarter results and raised its earnings outlook.

The company is gearing up for the rollout of its doughnuts at McDonald’s restaurants, starting in the Midwest with Chicago.

Analysts are always looking for historical parallels to current conditions. In a new note, UBS points to the third quarter of 2011..

Eli Lilly’s stock was headed for its best day in a year on Thursday, after the drugmaker reported second-quarter earnings that rose well above forecasts, amid strength in sales of its diabetes and obesity treatments, Mounjaro and Zepbound.

BP saw a broker downgrade on Thursday after analysts said its stock buyback is less sustainable than rival integrated oil companies.

Oil futures were off slightly early Thursday, consolidating after back-to-back gains.

Nvidia’s AI business can’t justify a $3 trillion valuation — but here’s what can, says a NYU finance professor.

“My other brother, who understands finances much better than me, says no one likes annuities.”

Located in a former textile factory building, the corner unit retains many century-old details in 3,000 square feet of chic living space.

The statement-making estate has a luxurious aesthetic with soaring ceilings and state-of-the -art gym.

U.S. bond yields fell early Thursday, reversing a move partly caused by a poor auction of 10-year notes on Wednesday, and amid concerns that new jobs data may provide further evidence of weakness in the U.S. economy.